Skip to content
Medicines Discovery Catapult
  • Speak to Us
Menu
Menu
  • What We Offer
  • How We Help
    • Success Stories
    • Partnership Opportunities
  • Areas of Focus
  • Our Capabilities
  • Our Technologies
  • Collaborators
  • Resources
  • About Us
    • Our Board
    • Our Leadership
    • Our People
    • Careers
  • Speak to Us

MDC Connects: A Guide to Complex Medicines

MDC Connects was a series of weekly webinars which ran in 2021. The sessions set out to educate, inform, and advise the community in drug discovery, focusing on recent trends and practice, encapsulating insight from experts in these areas. The sessions were aimed at small companies developing their own medicines but were equally open to the […]

Read more

Webinar – Complex Medicines: Ready for the Clinic/Scaling up for Success

The medicines industry is in a period of change. While small molecule therapeutics still make up 90% of approved medicines, patient expectations are driving the industry towards targeted, precision treatments, which require a shift towards stratified, complex medicines with more challenging discovery and development needs. MDC Connects 2021: A Guide to Complex Medicines is a […]

Read more

Webinar – Complex Medicines: Understanding Safety & Efficacy

The medicines industry is in a period of change. While small molecule therapeutics still make up 90% of approved medicines, patient expectations are driving the industry towards targeted, precision treatments, which require a shift towards stratified, complex medicines with more challenging discovery and development needs. MDC Connects 2021: A Guide to Complex Medicines is a […]

Read more

Webinar – Complex Medicines: A Glance at Novel Drug Delivery Systems

The medicines industry is in a period of change. While small molecule therapeutics still make up 90% of approved medicines, patient expectations are driving the industry towards targeted, precision treatments, which require a shift towards stratified, complex medicines with more challenging discovery and development needs. MDC Connects 2021: A Guide to Complex Medicines is a […]

Read more

Webinar – Complex Medicines: Understanding the Interplay with Biological Systems

The medicines industry is in a period of change. While small molecule therapeutics still make up 90% of approved medicines, patient expectations are driving the industry towards targeted, precision treatments, which require a shift towards stratified, complex medicines with more challenging discovery and development needs. MDC Connects 2021: A Guide to Complex Medicines is a […]

Read more

Webinar – Complex Medicines: Selection and Characterisation of the Lead

The medicines industry is in a period of change. While small molecule therapeutics still make up 90% of approved medicines, patient expectations are driving the industry towards targeted, precision treatments, which require a shift towards stratified, complex medicines with more challenging discovery and development needs. MDC Connects 2021: A Guide to Complex Medicines is a […]

Read more

Webinar – Complex Medicines: Why? What? When? Opportunities and Challenges

The medicines industry is in a period of change. While small molecule therapeutics still make up 90% of approved medicines, patient expectations are driving the industry towards targeted, precision treatments, which require a shift towards stratified, complex medicines with more challenging discovery and development needs. MDC Connects 2021: A Guide to Complex Medicines is a […]

Read more

Webinar – Developing a Biomarker Strategy

MDC Connects is a series of informative webinars covering the drug discovery process, from our own experts and experts at our CRO network partners. A common theme throughout our MDC Connects series is that of building confidence in a hypothesis and improving the chances of success in the clinic. To achieve success, the project team […]

Read more

Webinar – Is my Compound Safe?

MDC Connects is a series of informative webinars covering the drug discovery process, from our own experts and experts at our CRO network partners. Safety plays a huge part during preclinical development, and any drug must be extensively tested to regulatory standards before approval to test in humans.  Safety-related hazards can arise from target-mediated risk, […]

Read more

Let's Meet

Medicines Discovery Catapult
Block 35, Mereside
Alderley Park, Macclesfield
Cheshire
SK10 4ZF

  • 01625 238734
  • info@md.catapult.org.uk
  • Get Directions

Get in Touch

  • Speak to Us
  • Working with Us
  • LinkedIn
  • Twitter
  • Youtube
  • About Us
  • COVID-19
  • UK PET Network
  • Lighthouse Lab
  • Privacy Policy
  • Cookie Policy
  • Disclaimer
  • Modern Slavery
  • MDC logo
  • RDT Logo
  • UKRI logo

© 2022 Medicines Discovery Catapult. All rights reserved.

Catapult Network.

  • Catapult Network
  • Cell and Gene Therapy
  • Compound Semiconductor Applications
  • Connected Places
  • Digital
  • Energy Systems
  • High Value Manufacturing
  • Offshore Renewable Energy
  • Satellite Applications